Mitochondrial diseases (mito) are a highly complex set of rare genetic disorders. Mito can cause any symptom in any organ at any age. They rob the body’s cells of energy causing debilitating and often life-threatening organ dysfunction.
About 
 MITO
NEWS
					Watch our Webinar: The power of nutrition and mitochondrial diseases
Watch our Webinar: The power of nutrition and mitochondrial diseases As part of LHON Awareness Day, we hosted a powerful […]...
3 October 2025
Read more
					From Advocacy to Access: Mito Community Celebrates FDA Milestone
Barth syndrome therapy sets precedent for future treatments targeting mitochondrial dysfunction In a landmark decision, the U.S. Food and Drug […]...
26 September 2025
Read more
					IMP Launches New TK2d Video
IMP Launches New TK2d Video To mark TK2d Awareness Day 2025, we’ve released a new video that amplifyies the voices […]...
11 September 2025
Read more
					IMP Welcomes Three New Members
IMP now has members across three continents We’re delighted to welcome three new members to IMP. With these new members, […]...
9 September 2025
Read more
					Landmark Success for Mitochondrial Donation: A Milestone for Families Worldwide
The birth of eight healthy babies in the UK through mitochondrial donation (also known as Mitochondrial Replacement Therapy) has been […]...
17 July 2025
Read more
					Meet
a member
				
					
				The POLG Foundation
The PolG Foundation is committed to accelerating research efforts to develop effective treatments and, ultimately, a cure for POLG mitochondrial disorders.
							
			Become
a member
				Are you thinking of becoming an IMP member?
					About
IMP				
				
					International Mito Patients is a non-profit network of national patient organisations involved in mito. The national patient organisations support and advocate for patients, fund research, increase awareness and improve education in their country.
By joining forces, IMP represents a large group of patients, creating a stronger voice on an international level.
IMP’s mission is to increase the quality of life for people with mitochondrial disease by facilitating cross-border cooperation and collaboration among national patient organisations.